Surgery was performed on nine eyes of nine consecutive patients with chronic postoperative hypotony after prior vitreous surgery for retinal detachment and proliferative vitreoretinopathy. The operation included lysis of adhesions between the iris and the ciliary processes and removal of lens remnants and other fibrocellular tissue covering and/or causing traction on the pars plicata. The preoperative intraocular pressure was less than or equal to 5 mm Hg in all eyes, and the final postoperative intraocular pressure was 8 to 20 mm Hg in five eyes, 6 mm Hg in one eye, 4 mm Hg in one eye, and 0 mm Hg in two eyes. Minimum postoperative follow-up was 7 months and average follow-up was 10 months. This form of surgery to uncover and minimize traction on the ciliary body substantially increased the intraocular pressure in most of the treated cases and suggests that iridociliary adhesions and tissue proliferation covering and/or causing traction on the ciliary processes account for chronic postoperative hypotony in some cases after extensive surgery for proliferative vitreoretinopathy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00006982-199111020-00003 | DOI Listing |
Jpn J Ophthalmol
January 2025
Department of Ophthalmology, Osaka Rosai Hospital Clinical Research Center for Optical Sensory Organ Disability, 1179-3, Nagasone-cho, Kita-ku, Sakai, Osaka, 591-8025, Japan.
Purpose: To provide insights into the transscleral removal technique for subretinal proliferative tissues (SRP).
Study Design: Retrospective, single-center case series.
Methods: Patients who underwent transscleral removal of SRP during vitrectomy for rhegmatogenous retinal detachment (RRD) were included.
BMC Ophthalmol
January 2025
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Purpose: Proliferative vitreoretinopathy (PVR) is a complication of retinal detachment which requires multiple vitreoretinal surgical interventions and frequent use of oil endotamponade. In this study, we conducted an in-depth analysis of complications associated with the use of heavy silicone oil in the management of inferior PVR.
Methods: A retrospective cohort study of 20 eyes that underwent vitrectomy for inferior PVR with use of heavy silicone oil (Densiron 68) between March 2021 and October 2022 at Oxford Eye Hospital.
Free Radic Biol Med
January 2025
Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, P. R. China, No.251 Fu Kang Road, Nankai District, Tianjin 300384, P. R. China. Electronic address:
Proliferative vitreoretinopathy (PVR) is a major cause of rhegmatogenous retinal detachment repair failure. Despite many attempts to find therapeutics for PVR, no pharmacotherapy has been proven effective. Steroids, as the epitome, show uncertain clinical effectiveness, which lacks an explanation and hints at unappreciated mechanisms of PVR.
View Article and Find Full Text PDFOphthalmol Retina
January 2025
Byers Eye Institute, Stanford University, Palo Alto, CA,. Electronic address:
Purpose: We surveyed vitreoretinal (VR) fellowship program directors (PDs) to elucidate how they assess surgical competency among VR fellows. In addition, we also surveyed fellowship program graduates for the years 2022 and 2023 regarding assessment metrics and tools used during VR fellowship training.
Design: Web-based, cross-sectional descriptive study.
Sci Rep
January 2025
Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!